Recent studies of IL-4/IL-4 receptor (IL-4R) signaling in breast cancer cells in vitro and in vivo show enhanced cell survival and proliferation via signal transducer and activator of transcription (STAT)/protein kinase B (AKT)/mitogen-activated protein kinase (MAPK) signaling. This evidence concerns the gene IL4 and breast cancer.